News & Updates

Show Multimedia Only

NOACs in nonvalvular atrial fibrillation with multimorbidity: Where does apixaban stand?

02 Nov 2021

Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice, affecting millions of people globally. Stroke is one of its devastating complications, with the risk steeply increasing with advancing age. Additionally, AF is associated with more than a tripling of the risk of systemic embolic (SE) events. [J Am Heart Assoc 2020;9:e016724]

NOACs in nonvalvular atrial fibrillation with multimorbidity: Where does apixaban stand?

02 Nov 2021

Pembrolizumab extends RFS in stage II melanoma

01 Nov 2021 by

Pembrolizumab extended recurrence-free survival (RFS) in patients with high-risk stage II melanoma who had undergone complete resection, interim analysis results of the phase III KEYNOTE-716 trial showed.

Pembrolizumab extends RFS in stage II melanoma

01 Nov 2021

Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD

01 Nov 2021

Inflammatory bowel disease (IBD) patients receiving treatment with antitumour necrosis factor alpha (anti-TNFα) for more than 2 years represent a distinct group who obtain prolonged clinical benefit and tolerate maintenance treatment, according to a study.

Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD

01 Nov 2021

High cholesterol during pregnancy a harbinger of serious heart attack in offspring

31 Oct 2021 by

Having high cholesterol during pregnancy is associated with more serious acute myocardial infarction (AMI) in offspring in later life, suggests a retrospective study.

High cholesterol during pregnancy a harbinger of serious heart attack in offspring

31 Oct 2021

BP monitoring at home gathers most “likes” vs other methods

30 Oct 2021 by

People who need to check their blood pressure (BP) regularly to confirm if they have hypertension prefer BP monitoring done at home rather than at a clinic, kiosk, or through a 24-hour ambulatory BP monitoring (ABPM), suggest findings from the Blood Pressure Checks for Diagnosing Hypertension (BP-CHECK) trial presented at Hypertension 2021.

BP monitoring at home gathers most “likes” vs other methods

30 Oct 2021

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

30 Oct 2021 by

The intraoperative administration of dexamethasone in patients with non-immunogenic cancers may have survival benefits, according to a retrospective cohort study from the US presented at Anesthesiology 2021.

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

30 Oct 2021

What happens in women pregnant after COVID-19 vax?

29 Oct 2021 by

Vaccination with the ChAdOx1 nCoV-19 vaccine does not affect the rates of fertility, miscarriage, and other birth outcomes in women vaccinated before pregnancy, according to data from four ongoing clinical trials — adding to the body of evidence on the safety of COVID-19 vaccine in these women.

What happens in women pregnant after COVID-19 vax?

29 Oct 2021

Antidepressant useful in pain management following abdominal cancer surgery

29 Oct 2021

Administering a single dose of the serotonin and norepinephrine reuptake inhibitor (SNRI) duloxetine prior to a major abdominal cancer surgery leads to lower postoperative pain, reduced opioid requirement, and better quality of recovery, according to a study.

Antidepressant useful in pain management following abdominal cancer surgery

29 Oct 2021

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

29 Oct 2021 by

The combination of bamlanivimab and etesevimab reduces the risk of COVID-19-related hospitalization and any-cause death in high-risk ambulatory patients, particularly those with diabetes, according to the BLAZE-1* study presented at EASD 2021.

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

29 Oct 2021

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021 by

Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.

Post-ICH antiplatelet therapy not linked to recurrent ICH

28 Oct 2021

News & Updates

Showing Pharmacy articles

Showing

Specialty:

NOACs in nonvalvular atrial fibrillation with multimorbidity: Where does apixaban stand?

NOACs in nonvalvular atrial fibrillation with multimorbidity: Where does apixaban stand?

Pembrolizumab extends RFS in stage II melanoma

Pembrolizumab extends RFS in stage II melanoma

Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD

Sustained benefit with anti-TNFα less likely to lead to subsequent loss of response in IBD

High cholesterol during pregnancy a harbinger of serious heart attack in offspring

High cholesterol during pregnancy a harbinger of serious heart attack in offspring

BP monitoring at home gathers most “likes” vs other methods

BP monitoring at home gathers most “likes” vs other methods

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

What happens in women pregnant after COVID-19 vax?

What happens in women pregnant after COVID-19 vax?

Antidepressant useful in pain management following abdominal cancer surgery

Antidepressant useful in pain management following abdominal cancer surgery

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

Bamlanivimab + etesevimab combo reduces COVID-19-related hospitalization, any-cause death in high-risk patients

Post-ICH antiplatelet therapy not linked to recurrent ICH

Post-ICH antiplatelet therapy not linked to recurrent ICH